Assessing the safety of bioactive ingredients in infant formula that affect the immune system: recommendations from an expert panel

Emily A. Callahan(Tufts University), John B. Wallingford, Richard J. Deckelbaum(Columbia University), Josef Neu(University of Florida), Talal A. Chatila(Boston Children's Hospital), Kirsi M. Järvinen(ENT and Allergy), Catherine J. Field(University of Alberta), Frank R. Greer(University of Wisconsin–Madison), Ronald E. Kleinman(Harvard University), Joshua D. Milner(National Institute of Allergy and Infectious Diseases), Olle Hernell(Umeå University), Kinga K. Smolen(Boston Children's Hospital)
American Journal of Clinical Nutrition
October 7, 2021
10.1093/ajcn/nqab346
Cited by 10

Related Papers

JM2, encoding a fork head–related protein, is mutated in X-linked autoimmunity–allergic disregulation syndrome
|Journal of Clinical Investigation|2000|930
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
|Nature Genetics|2016|393
The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods
|PEDIATRICS|2019|388
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
|Journal of Allergy and Clinical Immunology|2018|261